• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地中海地区胃肠道间质瘤的发病率趋势及主要特征:一项基于人群的研究

Incidence Trends and Main Features of Gastro-Intestinal Stromal Tumours in a Mediterranean Region: A Population-Based Study.

作者信息

Vaamonde-Martín Ricardo J, Ballesta-Ruiz Mónica, Sánchez-Gil Antonia, Fernández Juan Ángel, Martínez-Barba Enrique, Martínez-García Jerónimo, Gatta Gemma, Chirlaque-López María D

机构信息

Service of Epidemiology, Region of Murcia Health Council, Ronda de Levante 11, 30008 Murcia, Spain.

Institute for Biomedical Research of Murcia, IMIB-Arrixaca, 30120 Murcia, Spain.

出版信息

Cancers (Basel). 2023 May 30;15(11):2994. doi: 10.3390/cancers15112994.

DOI:10.3390/cancers15112994
PMID:37296956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10251932/
Abstract

Gastro-Intestinal Stromal Tumours (GISTs) are a kind of neoplasm whose diagnosis in common clinical practice just started in the current century, implying difficulties for proper registration. Staff from the Cancer Registry of Murcia, in southeastern Spain, were commissioned by the EU Joint Action on Rare Cancers into a pilot study addressing GIST registration that also yielded a population-based depiction of GISTs in the region, including survival figures. We examined reports from 2001 to 2015 from hospitals as well as cases already present in the registry. The variables collected were sex, date of diagnosis, age, vital status, primary location, presence of metastases, and risk level according to Joensuu's Classification. In total, 171 cases were found, 54.4% occurred in males, and the mean age value was 65.0 years. The most affected organ was the stomach, with 52.6% of cases. Risk level was determined as "High" for 45.0%, with an increment of lower levels in recent years. Incidence for the year 2015 doubled that of 2001. Overall, the 5-year net survival estimation was 77.0%. The rising incidence magnitude is consistent with trends in other European countries. Survival evolution lacked statistical significance. A more interventional approach in clinical management could explain the increase in the proportion of "Low Risk GISTs" and the first occurrence of "Very Low Risk" in recent years.

摘要

胃肠道间质瘤(GISTs)是一种肿瘤,其在普通临床实践中的诊断于本世纪才刚刚开始,这意味着进行准确登记存在困难。西班牙东南部穆尔西亚癌症登记处的工作人员受欧盟罕见癌症联合行动委托,开展了一项关于GIST登记的试点研究,该研究还对该地区的GISTs进行了基于人群的描述,包括生存数据。我们查阅了2001年至2015年医院的报告以及登记处已有的病例。收集的变量包括性别、诊断日期、年龄、生命状态、原发部位、转移情况以及根据约恩苏分类法确定的风险水平。总共发现了171例病例,其中54.4%发生在男性身上,平均年龄值为65.0岁。受影响最严重的器官是胃,占病例的52.6%。45.0%的病例风险水平被确定为“高”,近年来较低风险水平的病例有所增加。2015年的发病率是2001年的两倍。总体而言,5年净生存估计为77.0%。发病率上升幅度与其他欧洲国家的趋势一致。生存演变缺乏统计学意义。临床管理中更具干预性的方法可能解释了近年来“低风险GISTs”比例的增加以及“极低风险”的首次出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbd6/10251932/55c9435e8ff5/cancers-15-02994-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbd6/10251932/d35f3d866869/cancers-15-02994-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbd6/10251932/55c9435e8ff5/cancers-15-02994-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbd6/10251932/d35f3d866869/cancers-15-02994-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbd6/10251932/55c9435e8ff5/cancers-15-02994-g002.jpg

相似文献

1
Incidence Trends and Main Features of Gastro-Intestinal Stromal Tumours in a Mediterranean Region: A Population-Based Study.地中海地区胃肠道间质瘤的发病率趋势及主要特征:一项基于人群的研究
Cancers (Basel). 2023 May 30;15(11):2994. doi: 10.3390/cancers15112994.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
4
Gastrointestinal Stromal Tumours of the Rectum - Evaluating the National Registry Data with Respect to its Use in Clinical Practice.直肠胃肠道间质瘤——评估国家登记数据在临床实践中的应用情况
Klin Onkol. 2019 Spring;32(2):117-123.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Temporal trends of incidence and survival of sarcoma of digestive tract including Gastrointestinal Stromal Tumours (GIST) in two areas of the north-east of Spain in the period 1981-2005: a population-based study.1981 - 2005年西班牙东北部两个地区包括胃肠道间质瘤(GIST)在内的消化道肉瘤发病率和生存率的时间趋势:一项基于人群的研究。
Clin Transl Oncol. 2014 Jul;16(7):660-7. doi: 10.1007/s12094-013-1131-0. Epub 2013 Nov 19.
7
[Differences in clinicopathological features, gene mutations, and prognosis between primary gastric and intestinal gastrointestinal stromal tumors in 1061 patients].1061例原发性胃和肠道胃肠道间质瘤的临床病理特征、基因突变及预后差异
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Apr 25;26(4):346-356. doi: 10.3760/cma.j.cn441530-20220531-00234.
8
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].[国家重点污染场地居民流行病学研究。第六次报告]
Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003.
9
Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases.胃肠道间质瘤(GISTs):66例临床病理及分子研究
Pathology. 2005 Feb;37(1):22-31. doi: 10.1080/00313020400023628.
10
Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy.原发性胃肠道间质瘤(GIST)完全切除后风险分类的再评估:辅助治疗的指征。
Gastric Cancer. 2015 Apr;18(2):426-33. doi: 10.1007/s10120-014-0386-7. Epub 2014 May 23.

引用本文的文献

1
Gastrointestinal Stromal Tumor: Current Approaches and Future Directions in the Treatment of Advanced Disease.胃肠道间质瘤:晚期疾病治疗的当前方法与未来方向
Hematol Oncol Clin North Am. 2025 Aug;39(4):773-784. doi: 10.1016/j.hoc.2025.04.006. Epub 2025 May 13.

本文引用的文献

1
Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules.胃肠道间质瘤(GISTs):免疫治疗和小分子的新治疗策略。
Int J Mol Sci. 2021 Jan 6;22(2):493. doi: 10.3390/ijms22020493.
2
Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU).罕见癌症清单的基本原理:欧盟(EU)罕见癌症联合行动(JARC)的共识文件。
ESMO Open. 2020 Mar;5(2). doi: 10.1136/esmoopen-2019-000666.
3
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design.
NCI-MATCH 试验:治疗选择的分子分析——对基因组试验设计的启示。
J Natl Cancer Inst. 2020 Oct 1;112(10):1021-1029. doi: 10.1093/jnci/djz245.
4
Comparative clinical features and short-term outcomes of gastric and small intestinal gastrointestinal stromal tumours: a retrospective study.胃和小肠胃肠道间质瘤的临床特征和短期预后比较:一项回顾性研究。
Sci Rep. 2019 Jul 11;9(1):10033. doi: 10.1038/s41598-019-46520-1.
5
Incidence of Gastrointestinal Stromal Tumors in the United States from 2001-2015: A United States Cancer Statistics Analysis of 50 States.2001 - 2015年美国胃肠道间质瘤发病率:基于美国50个州的癌症统计分析
Cureus. 2019 Feb 22;11(2):e4120. doi: 10.7759/cureus.4120.
6
Clinicopathological Features and Prognosis of Small Gastric Gastrointestinal Stromal Tumors (GISTs).胃小胃肠间质瘤的临床病理特征及预后。
J Gastrointest Surg. 2019 Nov;23(11):2136-2143. doi: 10.1007/s11605-018-04070-3. Epub 2019 Apr 22.
7
Defining Tumor Rupture in Gastrointestinal Stromal Tumor.定义胃肠道间质瘤的肿瘤破裂。
Ann Surg Oncol. 2019 Jun;26(6):1669-1675. doi: 10.1245/s10434-019-07297-9. Epub 2019 Mar 13.
8
Is the Surgical Margin in Gastrointestinal Stromal Tumors Different?胃肠道间质瘤的手术切缘是否不同?
Visc Med. 2018 Oct;34(5):347-352. doi: 10.1159/000491649. Epub 2018 Aug 24.
9
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.胃肠道间质瘤:ESMO-EURACAN诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv68-iv78. doi: 10.1093/annonc/mdy095.
10
Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era.在伊马替尼时代,胃肠道间质瘤患者的发病率和结局的全国性趋势。
Br J Surg. 2018 Jul;105(8):1020-1027. doi: 10.1002/bjs.10809. Epub 2018 Apr 17.